Category: Company News

Migraine Abortion Phase 3 Trial (TEAM study) with Cefaly® ACUTE Medical Device is Progressing Quickly

The Cefaly® ACUTE medical device, recently cleared by the U.S. Food and Drug Administration (FDA) for the acute treatment of migraine, is the subject of a large phase 3 clinical trial in the United States that is progressing rapidly. Previous

Tagged with: , , , , , , , ,

Chronic Migraine Prevention Trial Shows Positive Results for Cefaly® PREVENT Medical Device

The Cefaly® PREVENT medical device, approved by the U.S. Food and Drug Administration (FDA) for migraine prophylaxis in episodic migraine, was also successful in a recent trial for chronic migraine prevention. Previous pilot and pivotal trials (PREMICE1) demonstrated the efficacy

Tagged with: , , ,

Migraine Abortion Trial Shows Positive Results for Cefaly Acute Medical Device

The Cefaly® Acute medical device, cleared by the U.S. Food and Drug Administration (FDA) two months ago for the acute treatment of migraine with or without aura, was also successful in a recent trial for migraine abortion; and predominantly outperformed

Tagged with: , , , , , , , ,

FDA-Approved Cefaly Device to Stop Migraines Now Available

Renowned for helping prevent migraine attacks, a new FDA clearance paves way for more Cefaly devices that can now stop a migraine in progress and prevent a future episode too CEFALY Technology announces today the release of two new U.S. Food and

Tagged with: , , , , , , , , , , , , , , , ,

Imaging Study Expands Upon Previous Findings that Cefaly Device Is Effective in Blocking Migraine Pain

A new functional magnetic resonance imaging (fMRI) study expands upon previous findings that migraine medical device, Cefaly, successfully affects the metabolic activity in the areas of the brain affected among migraine patients. The new findings mark the third time in

Tagged with: , , , , , , , , , , , , , , , ,